A total of 75 patients suffering from benign prostatic hyperplasia (BHP) were treated with visual laser ablation of the prostate (VLAP) using the Nd-Yag laser. Preoperative evaluation consisted in determination of urinary flow and residual urine, assessment of voiding symptoms and urodynamic evaluation. Postoperatively, the same evaluation was performed at 3 and at 6 months. VLAP is a relatively simple technique with a low perioperative morbidity and short time results are comparable to classical transurethral resection of the prostate. Therefore VLAP seems to be an effective alternative treatment method for BPH which may replace classical transureteral resection of the prostate in a selected number of cases.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data.
Minerva Urol Nefrol
September 2009
Department of Urology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Unlabelled: Bladder outlet obstruction (BOO) is believed to be the major component of benign prostatic hyperplasia (BPH) that harms the urinary tract. Therefore, BOO relief is the primary treatment objective in patients with obstructive BPH. This systematic review aims to analyze urodynamic data of laser treatment modalities of the prostate in direct comparison with standard treatment (TURP or open prostatectomy).
View Article and Find Full Text PDFBilateral nerve-sparing extraperitoneal visual laser ablation radical prostatectomy: potency rates after 1 year follow up.
J Endourol
October 2008
Institute Santa Rita, São Paulo, Brazil.
Purpose: Wide variations exist in the methods for reporting potency following radical prostatectomy. In this group we used a validated questionnaires pre and post operatively to access relative return to normal sexual function after bilateral nerve-sparing visual laser ablation radical prostatectomy (VLAP).
Materials And Methods: One hundred and twenty four patients with ages ranging from 45 to 70 years old were evaluated in the period between January 2004 and March 2007.
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
Ont Health Technol Assess Ser
October 2012
Objective: The Ontario Health Technology Advisory Committee asked the Medical Advisory Secretariat (MAS) to conduct a health technology assessment on energy delivery systems for the treatment of benign prostatic hyperplasia (BPH).
Clinical Need: TARGET POPULATION AND CONDITION BPH is a noncancerous enlargement of the prostate gland and the most common benign tumour in aging men. (1) It is the most common cause of lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO) and is an important cause of diminished quality of life among aging men.
[Current view and critic of alternatives to transurethral surgery of prostatic benign prostate].
Arch Esp Urol
November 2003
Fundación Puigvert, C/Cartagena 340-350 08025 Barcelona, España.
Objectives: Critical update of transurethral surgery options based on the last decade most relevant bibliography.
Methods: Comparative study between Incision/TUR of the prostate and alternative techniques, accordingly to data from 30 randomized studies and 28 clinical studies. We evaluate efficiency, retreatment index, morbidity, post operative number of days with catheter, anesthetic requirements, and cost.
Free-beam and contact laser coagulation.
J Endourol
October 2003
Department of Urology, Diakoniekrankenhaus Academic Teaching Hospital, Rotenburg, Germany.
Laser coagulation of benign prostatic hyperplasia (BPH) encompasses a variety of techniques using different laser wavelengths, application systems, and surgical techniques to achieve contrasting tissue effects. During transurethral laser coagulation, known as visual laser ablation of the prostate (VLAP), the prostate is irradiated by free-beam Nd:YAG or diode laser energy. The coagulated and necrotic tissue sloughs off within weeks to months.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!